188 related articles for article (PubMed ID: 31136884)
1. Chemotherapy for gestational trophoblastic neoplasia patients with a FIGO score of 12 or greater: A multistudy analysis.
Li J; Yue H; Wang X; Chen R; Lu X
Eur J Obstet Gynecol Reprod Biol; 2019 Jul; 238():164-169. PubMed ID: 31136884
[TBL] [Abstract][Full Text] [Related]
2. Results with Floxuridine, Actinomycin D, Etoposide, and Vincristine in Gestational Trophoblastic Neoplasias with International Federation of Gynecology and Obstetrics Scores ≥5.
Li Y; Kong Y; Wan X; Feng F; Ren T; Zhao J; Yang J; Xiang Y
Oncologist; 2021 Dec; 26(12):e2209-e2216. PubMed ID: 34396643
[TBL] [Abstract][Full Text] [Related]
3. [Impact of chemotherapy on ovarian function and quality of life of patients with gestational trophoblastic neoplasia].
Xue W; Yang JJ; Zhao J; Ren T; Feng FZ; Wan XR; Xiang Y
Zhonghua Fu Chan Ke Za Zhi; 2018 Jun; 53(6):377-383. PubMed ID: 29961279
[No Abstract] [Full Text] [Related]
4. [EMA/CO regimen for chemotherapy 24 patients with ultra high-risk gestational trophoblastic neoplasia].
Shen T; Chen LL; Qin JL; Wang XY; Cheng XD; Xie X; Lyu WG
Zhonghua Fu Chan Ke Za Zhi; 2018 Jun; 53(6):371-376. PubMed ID: 29961278
[No Abstract] [Full Text] [Related]
5. Importance of salvage therapy in the management of high-risk gestational trophoblastic neoplasia.
Lurain JR; Schink JC
J Reprod Med; 2012; 57(5-6):219-24. PubMed ID: 22696816
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapy for resistant or recurrent gestational trophoblastic neoplasia.
Alazzam M; Tidy J; Osborne R; Coleman R; Hancock BW; Lawrie TA
Cochrane Database Syst Rev; 2012 Dec; 12():CD008891. PubMed ID: 23235667
[TBL] [Abstract][Full Text] [Related]
7. Chemotherapy for resistant or recurrent gestational trophoblastic neoplasia.
Alazzam M; Tidy J; Osborne R; Coleman R; Hancock BW; Lawrie TA
Cochrane Database Syst Rev; 2016 Jan; 2016(1):CD008891. PubMed ID: 26760424
[TBL] [Abstract][Full Text] [Related]
8. EMA/CO for high-risk gestational trophoblastic neoplasia: good outcomes with induction low-dose etoposide-cisplatin and genetic analysis.
Alifrangis C; Agarwal R; Short D; Fisher RA; Sebire NJ; Harvey R; Savage PM; Seckl MJ
J Clin Oncol; 2013 Jan; 31(2):280-6. PubMed ID: 23233709
[TBL] [Abstract][Full Text] [Related]
9. M-EA (methotrexate, etoposide, dactinomycin) and EMA-CO (methotrexate, etoposide, dactinomycin / cyclophosphamide, vincristine) regimens as first-line treatment of high-risk gestational trophoblastic neoplasia.
Singh K; Gillett S; Ireson J; Hills A; Tidy JA; Coleman RE; Hancock BW; Winter MC
Int J Cancer; 2021 May; 148(9):2335-2344. PubMed ID: 33210289
[TBL] [Abstract][Full Text] [Related]
10. Relapsed or refractory gestational trophoblastic neoplasia treated with the etoposide and cisplatin/etoposide, methotrexate, and actinomycin D (EP-EMA) regimen.
Mao Y; Wan X; Lv W; Xie X
Int J Gynaecol Obstet; 2007 Jul; 98(1):44-7. PubMed ID: 17481633
[TBL] [Abstract][Full Text] [Related]
11. Efficacies of FAEV and EMA/CO regimens as primary treatment for gestational trophoblastic neoplasia.
Ji M; Jiang S; Zhao J; Wan X; Feng F; Ren T; Yang J; Xiang Y
Br J Cancer; 2022 Aug; 127(3):524-530. PubMed ID: 35459802
[TBL] [Abstract][Full Text] [Related]
12. EP-EMA regimen (etoposide and cisplatin with etoposide, methotrexate, and dactinomycin) in a series of 18 women with gestational trophoblastic neoplasia.
Han SN; Amant F; Leunen K; Devi UK; Neven P; Vergote I
Int J Gynecol Cancer; 2012 Jun; 22(5):875-80. PubMed ID: 22635033
[TBL] [Abstract][Full Text] [Related]
13. Actinomycin D, cisplatin, and etoposide regimen is associated with almost universal cure in patients with high-risk gestational trophoblastic neoplasia.
Even C; Pautier P; Duvillard P; Floquet A; Kerbrat P; Troalen F; Rey A; Balleyguier C; Tazi Y; Leary A; Augereau P; Morice P; Droz JP; Fizazi K; Lhommé C
Eur J Cancer; 2014 Aug; 50(12):2082-9. PubMed ID: 24910417
[TBL] [Abstract][Full Text] [Related]
14. [Curative effects and influenced factors of EMA-CO as an initial regimen for the treatment of high-risk gestational trophoblastic neoplasia].
Liu W; Zhao W; Zhang YQ; Huang XF
Zhonghua Yi Xue Za Zhi; 2018 Dec; 98(47):3896-3899. PubMed ID: 30585038
[No Abstract] [Full Text] [Related]
15. Salvage chemotherapy for gestational trophoblastic neoplasia: Utility or futility?
Essel KG; Bruegl A; Gershenson DM; Ramondetta LM; Naumann RW; Brown J
Gynecol Oncol; 2017 Jul; 146(1):74-80. PubMed ID: 28473205
[TBL] [Abstract][Full Text] [Related]
16. Treatment of high-risk gestational trophoblastic neoplasia with etoposide, methotrexate, actinomycin D, cyclophosphamide, and vincristine chemotherapy.
Escobar PF; Lurain JR; Singh DK; Bozorgi K; Fishman DA
Gynecol Oncol; 2003 Dec; 91(3):552-7. PubMed ID: 14675675
[TBL] [Abstract][Full Text] [Related]
17. Mortality rate of gestational trophoblastic neoplasia with a FIGO score of ≥13.
Bolze PA; Riedl C; Massardier J; Lotz JP; You B; Schott AM; Hajri T; Golfier F
Am J Obstet Gynecol; 2016 Mar; 214(3):390.e1-8. PubMed ID: 26433171
[TBL] [Abstract][Full Text] [Related]
18. Primary treatment of stage IV gestational trophoblastic neoplasia with floxuridine, dactinomycin, etoposide and vincristine (FAEV): A report based on our 10-year clinical experiences.
Yang J; Xiang Y; Wan X; Feng F; Ren T
Gynecol Oncol; 2016 Oct; 143(1):68-72. PubMed ID: 27426306
[TBL] [Abstract][Full Text] [Related]
19. Leptomeningeal disease as a presenting feature of gestational trophoblastic neoplasia: A review and recommendations for management.
Hapuarachi B; Tidy JA; Romanowski C; Singh K; Gillett S; Ireson J; Winter MC
Gynecol Oncol; 2023 May; 172():47-53. PubMed ID: 36934478
[TBL] [Abstract][Full Text] [Related]
20. High-risk metastatic gestational trophoblastic neoplasia. Primary management with EMA-CO (etoposide, methotrexate, actinomycin D, cyclophosphamide and vincristine) chemotherapy.
Cagayan MS
J Reprod Med; 2012; 57(5-6):231-6. PubMed ID: 22696818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
